Barclays PLC
BCLYF
$4.12
$0.1152.87%
Weiss Ratings | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Excellent | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | A | |||
Rating Factors | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Excellent | |||
Growth Index | Fair | |||
Efficiency Index | Good | |||
Solvency Index | Good | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.11 | |||
Price History | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 10.14% | |||
30-Day Total Return | 18.54% | |||
60-Day Total Return | 20.59% | |||
90-Day Total Return | 38.95% | |||
Year to Date Total Return | 27.55% | |||
1-Year Total Return | 99.64% | |||
2-Year Total Return | 104.93% | |||
3-Year Total Return | 111.55% | |||
5-Year Total Return | 145.09% | |||
52-Week High % Change | -3.03% | |||
52-Week Low % Change | 105.38% | |||
Price | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $4.13 | |||
52-Week Low Price | $1.95 | |||
52-Week Low Price (Date) | Mar 06, 2024 | |||
52-Week High Price (Date) | Mar 05, 2025 | |||
Valuation | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 55.51B | |||
Enterprise Value | -- | |||
Price/Earnings (TTM) | 8.82 | |||
Earnings Per Share (TTM) | 0.45 | |||
Earnings Per Share Growth | 36.04% | |||
Price/Earnings To Growth | 0.24 | |||
Price/Sales (TTM) | 1.87 | |||
Price/Book (Q) | 0.77 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $4.12 | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -- | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 14.43B | |||
Dividend Yield | 2.10% | |||
Div. Per Share (Most Recent) | $0.06 | |||
Dividend Per Share (TTM) | $0.08 | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | $0.06 | |||
Company Info | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 44 20 7116 1000 | |||
Address | -- | |||
Website | home.barclays | |||
Country | United Kingdom | |||
Year Founded | 1690 | |||
Profitability | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 32.99% | |||
Profit Margin | 26.02% | |||
Management Effectiveness | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | 8.92% | |||
Income Statement | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 16.96B | |||
Total Revenue (TTM) | 30.99B | |||
Revenue Per Share | $2.15 | |||
Gross Profit (TTM) | 30.99B | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | 8.06B | |||
Net Income Avl. to Common (TTM) | 8.06B | |||
Total Revenue Growth (Q YOY) | 16.40% | |||
Earnings Growth (Q YOY) | 840.29% | |||
EPS Diluted (TTM) | 0.45 | |||
EPS Diluted Growth (Q YOY) | 1,039.56% | |||
Balance Sheet | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.08T | |||
Cash Per Share (Q) | $75.12 | |||
Total Current Assets (Q) | 1.25T | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 90.74B | |||
Current Ratio (Q) | 0.784 | |||
Book Value Per Share (Q) | $5.19 | |||
Total Assets (Q) | 1.90T | |||
Total Current Liabilities (Q) | 1.60T | |||
Total Debt (Q) | 826.50B | |||
Total Liabilities (Q) | 1.81T | |||
Total Common Equity (Q) | 89.91B | |||
Cash Flow | BCLYF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||